Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/124332
dc.contributor.author | Laquente, Berta |
---|---|
dc.contributor.author | Lopez Martin, Jose |
dc.contributor.author | Richards, Donald |
dc.contributor.author | Illerhaus, Gerald |
dc.contributor.author | Chang, David Z. |
dc.contributor.author | Kim, George |
dc.contributor.author | Stella, Philip |
dc.contributor.author | Richel, Dirk |
dc.contributor.author | Szcylik, Cezary |
dc.contributor.author | Cascinu, Stefano |
dc.contributor.author | Frassineti, G. L. |
dc.contributor.author | Ciuleanu, Tudor |
dc.contributor.author | Hurt, Karla |
dc.contributor.author | Hynes, Scott |
dc.contributor.author | Lin, Ji |
dc.contributor.author | Lin, Aimee Bence |
dc.contributor.author | Hoff, Daniel Von |
dc.contributor.author | Calvo, Emiliano |
dc.date | 2018-09-06T07:20:25Z |
dc.date | 2018-09-06T07:20:25Z |
dc.date | 2017-02-14 |
dc.date | 2018-07-24T12:10:43Z |
dc.identifier.uri | http://hdl.handle.net/2445/124332 |
dc.format | 9 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | BioMed Central |
dc.relation | Reproducció del document publicat a: https://doi.org/10.1186/s12885-017-3131-x |
dc.relation | BMC Cancer, 2017, vol. 17, num. 137 |
dc.relation | https://doi.org/10.1186/s12885-017-3131-x |
dc.rights | cc by (c) Laquente et al., 2017 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by/3.0/es/ |
dc.subject | Càncer de pàncrees |
dc.subject | Quimioteràpia |
dc.subject | Pancreas cancer |
dc.subject | Chemotherapy |
dc.title | A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |